company background image
300391 logo

Changjiang Pharmaceutical Group SZSE:300391 Stock Report

Last Price

CN¥4.05

Market Cap

CN¥1.4b

7D

0.2%

1Y

-46.2%

Updated

01 May, 2024

Data

Company Financials

Changjiang Pharmaceutical Group Co., Ltd.

SZSE:300391 Stock Report

Market Cap: CN¥1.4b

300391 Stock Overview

Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the production and distribution of pharmaceuticals and photovoltaic equipment in China and internationally.

300391 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Changjiang Pharmaceutical Group Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Changjiang Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥4.05
52 Week HighCN¥8.96
52 Week LowCN¥2.76
Beta0.15
1 Month Change-22.86%
3 Month Change-26.23%
1 Year Change-46.22%
3 Year Change-68.33%
5 Year Change-55.10%
Change since IPO7.18%

Recent News & Updates

Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

Apr 17
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%

Feb 27
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%

Recent updates

Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

Apr 17
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%

Feb 27
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%

Shareholder Returns

300391CN Auto ComponentsCN Market
7D0.2%7.1%4.2%
1Y-46.2%10.5%-13.2%

Return vs Industry: 300391 underperformed the CN Auto Components industry which returned 10.5% over the past year.

Return vs Market: 300391 underperformed the CN Market which returned -13.2% over the past year.

Price Volatility

Is 300391's price volatile compared to industry and market?
300391 volatility
300391 Average Weekly Movement16.5%
Auto Components Industry Average Movement9.3%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 300391's share price has been volatile over the past 3 months.

Volatility Over Time: 300391's weekly volatility has increased from 9% to 16% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1963613Ming Luowww.chinakangyue.com

Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the production and distribution of pharmaceuticals and photovoltaic equipment in China and internationally. It offers photovoltaic equipment, such as laminating machines and stitch welding machines; tablets and hollow capsules; and Chinese herbal beverages, as well as engages in pharmaceutical distribution business. The company was formerly known as Kangyue Technology Co., Ltd.

Changjiang Pharmaceutical Group Co., Ltd. Fundamentals Summary

How do Changjiang Pharmaceutical Group's earnings and revenue compare to its market cap?
300391 fundamental statistics
Market capCN¥1.42b
Earnings (TTM)-CN¥630.20m
Revenue (TTM)CN¥1.12b

1.3x

P/S Ratio

-2.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300391 income statement (TTM)
RevenueCN¥1.12b
Cost of RevenueCN¥930.51m
Gross ProfitCN¥189.35m
Other ExpensesCN¥819.55m
Earnings-CN¥630.20m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.80
Gross Margin16.91%
Net Profit Margin-56.27%
Debt/Equity Ratio88.2%

How did 300391 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.